Studies pain and sex hormones in endometriosis and migraine
Compares pain sensitivity and hormone levels in people with endometriosis, migraine, or both.
Plain-language title generated from the registry record
Registry title: Endometriosis and Migraine
Key facts
- Where
- St Louis, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 45 years old?
Source: NCT06785129, who can take part
Where in United States
- Washington University School of MedicineSt Louis, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Washington University School of Medicine
- Trial code
- NCT06785129
- Record updated
- 13 July 2026
- Original description
This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.Read full original descriptionShow less
Mechanisms Underlying Endometriosis and Migraine Comorbidity
This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.
Inclusion: Patients with diagnosed endometriosis, migraine, or both endometriosis and migraine; Healthy control subjects with no history of chronic pain; Age 12-45; Assigned female sex at birth.
Exclusion: Current use of dopamine agonist or SSRI medications; Presence of psychiatric, neurological, endocrinological and/or developmental conditions and taking medications for these conditions; For patients aged 12-17 not having a parent/legal guardian willing to sign the consent and answer surveys about their child's health; Pregnancy or breastfeeding; Presence of prolactinoma.